This paper is in the following e-collection/theme issue:

NIH funded proposals with peer-review reports (USA) (112) Hearing Impairment and Hearing Loss (87) Accessibility (19) Disabilities (157) Doctor-Patient Communication on Cancer, Prevention, and Screening (78) Mobile Apps for Cancer Care and Cancer Prevention and Screening (265) Telehealth and Telemonitoring (2085) Equity and Digital Divide (370)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65078, first published .
Using American Sign Language–Fluent Community Health Navigators to Advance Cancer Screening Adherence through Videoconferencing With Deaf, Deafblind, and Hard of Hearing Adults: Protocol for a Randomized Controlled Trial

Using American Sign Language–Fluent Community Health Navigators to Advance Cancer Screening Adherence through Videoconferencing With Deaf, Deafblind, and Hard of Hearing Adults: Protocol for a Randomized Controlled Trial

Using American Sign Language–Fluent Community Health Navigators to Advance Cancer Screening Adherence through Videoconferencing With Deaf, Deafblind, and Hard of Hearing Adults: Protocol for a Randomized Controlled Trial

Authors of this article:

Poorna Kushalnagar1 Author Orcid Image ;   Sowmya R Rao2 Author Orcid Image ;   Erika Bergeron1 Author Orcid Image ;   Rupa Valdez3 Author Orcid Image ;   Regina Wang4 Author Orcid Image ;   Raja S Kushalnagar5 Author Orcid Image ;   Georgia R Sadler6 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Poorna Kushalnagar   1 , PhD ;   Sowmya R Rao   2 , PhD ;   Erika Bergeron   1 , MPH ;   Rupa Valdez   3 , PhD ;   Regina Wang   4 , MD ;   Raja S Kushalnagar   5 , LLM, JD, PhD ;   Georgia R Sadler   6 , BSN, MBA, PhD

1 Center of Deaf Health Excellence, Gallaudet University, Washington, DC, United States

2 School of Public Health, Boston University, Boston, MA, United States

3 Department of Public Health Sciences, University of Virginia, Charlottesville, VA, United States

4 UC San Diego Health System, La Jolla, CA, United States

5 School of Science, Technology, Accessibility, Mathematics, and Public Health, Gallaudet University, Washington, DC, United States

6 Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States

Corresponding Author: